ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
Home
Press release
Apr, 17 2018 19:30 JST
Source:
Jacobson Pharma Corporation Limited
Jacobson Pharma Ranked No. 1 in "Hong Kong Best Small-Cap Company" in the "Asia's Best Companies Poll 2018" by FinanceAsia
HONG KONG, Apr, 17 2018 - (ACN Newswire) - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, is pleased to announce that Jacobson Pharma ranked no.1 in the category of Hong Kong Best Small-Cap Company in the "Asia's Best Companies Poll 2018" conducted by FinanceAsia, an authoritative financial magazine in Asia.
Mr. Derek Sum, Chairman and Chief Executive Officer of Jacobson Pharma, said, "We are very proud of being ranked no.1 of the Best Small-cap Company and gain strong recognition in the investment community. This is also a clear acknowledgment of our dedication to excellence in all aspects of corporate management and corporate governance. I would like to take this opportunity to thank all investors and analysts who have cast their vote for Jacobson Pharma for their ongoing support and solid confidence in the Group's bright prospects.
Looking ahead, the management team will continue to strive for a healthy business momentum and realize the growth strategies in line with our original plans and schedule. We will continue to take a measured and disciplined approach to R&D investment as well as expand our footprint in certain strategic markets in Asia with a view to creating sustainable value for our shareholders".
Jacobson Pharma reported sound financial results for the six months ended 30 September 2017, with the Group's revenue increasing by 29.1% to HK$743.0 million. Profit attributable to the shareholders of the Group surged by 40.6% to HK$80.3 million.
Asia's Best Companies Poll 2018, held for the eighteenth consecutive year, is conducted by the leading regional financial publication FinanceAsia. All of the awards were nominated and voted by institutional investors or analysts from across Asia. Investment professionals are requested to rank companies in key categories, including corporate governance, investor relations, commitment to dividends, etc.
For more details about the Asia's Best Companies Poll 2018 results, please visit:
http://www.financeasia.com/News/443867,investors-vote-best-managed-companies-in-hk-china-taiwan.aspx
About Jacobson Pharma Corporation Limited (Stock Code: 2633)
Jacobson Pharma is the largest generic drug company in Hong Kong with over 30% share of the total generic drug market for each year since 2012. The Group's proprietary medicines, notably being Po Chai Pills, Tong Tai Chung Woodlok Oil, Ho Chai Kung Tji Thung San, Contractubex Scar Gel Doan's Ointment, Flying Eagle Wood Lok Medicated Oil, Saplingtan, Shiling Oil and Col-gan Tablet have been widely recognised by the market. Jacobson Pharma has been a constituent stock of MSCI Hong Kong Micro Cap Index since 1 June 2017. For more details about Jacobson Pharma, please visit the Group's website:
http://www.jacobsonpharma.com
For media enquiries, please contact:
Strategic Financial Relations Limited
Vicky Lee Tel: (852) 2864 4834 Email:
[email protected]
Angela Ng Tel: (852) 2864 4855 Email:
[email protected]
Queenie Chan Tel: (852) 2864 4851 Email:
[email protected]
Fax: (852) 2527 1196
About Jacobson Pharma Corporation Limited
Jacobson Pharma is the largest generic drug company in Hong Kong with over 30% share of the total generic drug market for each year since 2012 according to Frost & Sullivan. The Group's proprietary medicines, notably being Po Chai Pills, Tong Tai Chung Woodlok Oil, Chai Kung Tji Thung San, Contractubex Scar Gel Doan's Ointment, Flying Eagle Wood Lok Medicated Oil, Saplingtan, Shiling Oil and Col-gan Tablet are widely carried in the market. For more details about Jacobson Pharma, please visit the Group's website:
http://www.jacobsonpharma.com
Source: Jacobson Pharma Corporation Limited
Sectors: Daily Finance, HealthCare
Copyright ©2019 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
DOCOMO and Kyoto University Develop World's First AI System to Detect Bridge Deterioration using Video-based Vehicle Weights and Structural Deflection
Dec 05, 2019 14:17 JST
Fujitsu Successfully Grows Diamond Film to Boost Heat Dissipation Efficiency of GaN HEMT
Dec 05, 2019 13:06 JST
KMD buys IT System for Disaster Assistance from Plass Data
Dec 05, 2019 12:31 JST
Fujitsu Takes Key Step Toward Implementing SAP S/4HANA Manufacturing for Production Engineering and Operations to Streamline Aircraft Production at Kawasaki Heavy Industries
Dec 05, 2019 11:11 JST
Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symposium
Dec 05, 2019 09:11 JST
Mitsubishi Corporation: Dedicated Biomass Power Generation at Suzukawa Energy Center
Dec 04, 2019 16:35 JST
Panasonic and Toyota Confirm Location and Executive Structure of Town Development Joint Venture
Dec 04, 2019 15:32 JST
Mitsubishi Corporation Establishes New Tech Subsidiary, MC Digital
Dec 03, 2019 16:49 JST
MHI Thermal Systems Wins 22nd "Environment Minister's Award for Global Warming Prevention Activity" for its High-efficiency Next-generation ETI-Z Series Centrifugal Chillers
Dec 03, 2019 15:08 JST
Hitachi: Power Grid Protection System Starts its Demonstration Operation in Poland
Dec 03, 2019 12:31 JST
MHPS to Exhibit at the Japan Pavilion at COP25 in Madrid, Spain from December 2
Dec 02, 2019 16:32 JST
Fujitsu Begins Shipping Supercomputer Fugaku
Dec 02, 2019 13:23 JST
Mitsubishi Heavy Industries Asia Pacific Establishes Yangon Representative Office
Dec 02, 2019 12:57 JST
Eisai to Present Latest Data on Alzheimer's Disease / Dementia Pipeline at 12th Clinical Trials on Alzheimer's Disease Conference
Dec 02, 2019 09:23 JST
Eisai: Additional Indication for Lenvima (Lenvatinib) for Differentiated Thyroid Cancer Accepted in China
Dec 02, 2019 09:08 JST
Showa Denko Announces Changes in Representative Director and Other Members of Management
Nov 29, 2019 16:00 JST
Fujitsu Laboratories and Aichi Cancer Center in Japan Sign Comprehensive Joint Research Agreement to Drive Advances in Cancer Genomic Medicine with AI Technology
Nov 29, 2019 11:17 JST
Mitsubishi Shipbuilding Holds Christening and Launch Ceremony in Shimonoseki for Cargo-Passenger Ship for Tokai Kisen
Nov 28, 2019 13:30 JST
Mazda Production and Sales Results for October 2019
Nov 28, 2019 12:25 JST
Ogier, Evans and Rovanpera: An Exciting New Line-Up to Drive the Toyota Yaris WRC in 2020
Nov 28, 2019 08:51 JST
More Latest Release >>
Related Release
Jacobson Pharma Announces FY2020 Interim Results
November 26 2019 17:24 JST
Jacobson Pharma Launches Smartfish Health Nutrition Products from Norway in Greater China and Asia Pacific Region
November 12 2019 21:05 JST
Jacobson Pharma Adds Excilor to Its Portfolio to Develop China Market with Vemedia (The Netherlands)
November 05 2019 23:05 JST
Jacobson Pharma Forms Joint Venture with Kin Fung Weisen-U
October 31 2019 20:25 JST
HKTDC Food Expo opens featuring new Coffee Avenue zone
August 15 2019 19:00 JST
Jacobson Pharma Announces FY2019 Annual Results
June 25 2019 20:00 JST
Jacobson Pharma and Yunnan Baiyao Group to Continue Exploring Further Possibilities of Business Cooperation and Other Collaborations
May 08 2019 20:15 JST
Jacobson Pharma Issues Positive Profit Alert
May 02 2019 22:39 JST
Jacobson Pharma Announces FY2019 Interim Results
November 21 2018 22:43 JST
Jacobson Pharma Announces 2018 Annual Results
June 25 2018 20:48 JST
More Press release >>